tiprankstipranks
Advertisement
Advertisement
VolitionRx Shareholders Approve Stock Issuance and Reverse Split
PremiumCompany AnnouncementsVolitionRx Shareholders Approve Stock Issuance and Reverse Split
20d ago
Is VNRX a Buy, Before Earnings?
Premium
Pre-Earnings
Is VNRX a Buy, Before Earnings?
24d ago
Morning News Wrap-Up 3/25/26: Today’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up 3/25/26: Today’s Biggest Stock Market Stories!
27d ago
VolitionRx files to sell 17.97M shares of common stock for holders
PremiumThe FlyVolitionRx files to sell 17.97M shares of common stock for holders
2M ago
VolitionRx preparing reimbursement submission for Nu.Q cancer assays in France
Premium
The Fly
VolitionRx preparing reimbursement submission for Nu.Q cancer assays in France
3M ago
VolitionRx adds two laboratories providing its vet cancer test in U.S. and Asia
Premium
The Fly
VolitionRx adds two laboratories providing its vet cancer test in U.S. and Asia
3M ago
VolitionRx downgraded to Hold from Buy at Maxim
PremiumThe FlyVolitionRx downgraded to Hold from Buy at Maxim
5M ago
VolitionRx price target lowered to $1.50 from $2.50 at H.C. Wainwright
Premium
The Fly
VolitionRx price target lowered to $1.50 from $2.50 at H.C. Wainwright
5M ago
VolitionRx Ltd. Earnings Call Highlights Growth and Partnerships
Premium
Company Announcements
VolitionRx Ltd. Earnings Call Highlights Growth and Partnerships
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100